Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Income towards Parent Company (2016 - 2025)

Apyx Medical (APYX) has disclosed Income towards Parent Company for 15 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 105.88% year-over-year to -$1.2 million, compared with a TTM value of -$11.1 million through Dec 2025, down 604.09%, and an annual FY2025 reading of -$11.1 million, down 604.09% over the prior year.
  • Income towards Parent Company was -$1.2 million for Q4 2025 at Apyx Medical, up from -$2.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $21.1 million in Q4 2024 and bottomed at -$9.6 million in Q4 2023.
  • Average Income towards Parent Company over 5 years is -$3.3 million, with a median of -$4.5 million recorded in 2021.
  • Peak annual rise in Income towards Parent Company hit 319.27% in 2024, while the deepest fall reached 546.32% in 2024.
  • Year by year, Income towards Parent Company stood at -$2.0 million in 2021, then crashed by 201.74% to -$6.1 million in 2022, then crashed by 58.68% to -$9.6 million in 2023, then surged by 319.27% to $21.1 million in 2024, then tumbled by 105.88% to -$1.2 million in 2025.
  • Business Quant data shows Income towards Parent Company for APYX at -$1.2 million in Q4 2025, -$2.0 million in Q3 2025, and -$3.7 million in Q2 2025.